The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Inherited NUDT15 Variant Is a Genetic Determinant of Mercaptopurine Intolerance in Children With Acute Lymphoblastic Leukemia
Open accessAbstract
Purpose: Mercaptopurine (MP) is the mainstay of curative therapy for acute lymphoblastic leukemia (ALL). We performed a genome-wide association study (GWAS) to identify comprehensively the genetic basis of MP intolerance in children with ALL. Patients and Methods: The discovery GWAS and replication cohorts included 657 and 371 children from two prospective clinical trials. MP dose intensity was a marker for drug tolerance and toxicities and was defined as prescribed dose divided by the planned protocol dose during maintenance therapy; its association with genotype was evaluated using a linear mixed-effects model. Results: MP dose intensity varied by race and ethnicity and was negatively correlated with East Asian genetic ancestry (P < .001). The GWAS revealed two genome-wide significant loci associated with dose intensity: rs1142345 in TPMT (Tyr240Cys, present in *3A and *3C variants; P = 8.6 × 10−9) and rs116855232 in NUDT15 (P = 8.8 × 10−9), with independent replication. Patients with TT genotype at rs116855232 were exquisitely sensitive to MP, with an average dose intensity of 8.3%, compared with those with TC and CC genotypes, who tolerated 63% and 83.5% of the planned dose, respectively. The NUDT15 variant was most common in East Asians and Hispanics, rare in Europeans, and not observed in Africans, contributing to ancestry-related differences in MP tolerance. Of children homozygous for either TPMT or NUDT15 variants or heterozygous for both, 100% required ≥ 50% MP dose reduction, compared with only 7.7% of others. Conclusion: We describe a germline variant in NUDT15 strongly associated with MP intolerance in childhood ALL, which may have implications for treatment individualization in this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inference of Population Structure Using Multilocus Genotype Data
Pritchard, J. K., Stephens, M., & Donnelly, P. (2000) · Genetics · doi:10.1093/genetics/155.2.945 · Cited by 33,908
Principal components analysis corrects for stratification in genome-wide association studies
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006) · Nature Genetics · doi:10.1038/ng1847 · Cited by 10,248
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
Evans, W. E., & Relling, M. V. (1999) · Science · doi:10.1126/science.286.5439.487 · Cited by 2,475
Self-citationTreating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation
Pui, C.-H., Campana, D., Pei, D., Bowman, W. P., Sandlund, J. T., Kaste, S. C., Ribeiro, R. C., Rubnitz, J. E., Raimondi, S. C., Onciu, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900386 · Cited by 1,215
Self-citationHunger, S. P., Lu, X., Devidas, M., Camitta, B. M., Gaynon, P. S., Winick, N. J., Reaman, G. H., & Carroll, W. L. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.8018 · Cited by 1,180
Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update
Pui, C.-H., Carroll, W. L., Meshinchi, S., & Arceci, R. J. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.7405 · Cited by 842
Self-citationMoving towards individualized medicine with pharmacogenomics
Evans, W. E., & Relling, M. V. (2004) · Nature · doi:10.1038/nature02626 · Cited by 768
Self-citationYates, C. R., Krynetski, E. Y., Loennechen, T., Fessing, M. Y., Tai, H.-L., Pui, C.-H., Relling, M. V., & Evans, W. E. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-8-199704150-00003 · Cited by 756
Self-citationRelling, M. V., Hancock, M. L., Rivera, G. K., Sandlund, J. T., Ribeiro, R. C., Krynetski, E. Y., Pui, C.-H., & Evans, W. E. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.23.2001 · Cited by 733
Self-citationGenetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia
Lennard, L., Lilleyman, J. S., Van Loon, J., & Weinshilboum, R. M. (1990) · The Lancet · doi:10.1016/0140-6736(90)91745-v · Cited by 651
Genetic Variation and Population Structure in Native Americans
Wang, S., Lewis, C. M., Jakobsson, M., Ramachandran, S., Ray, N., Bedoya, G., Rojas, W., Parra, M. V., Molina, J. A., Gallo, C., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030185 · Cited by 619
Relling, M. V., Gardner, E. E., Sandborn, W. J., Schmiegelow, K., Pui, C.-H., Yee, S. W., Stein, C. M., Carrillo, M., Evans, W. E., & Klein, T. E. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.320 · Cited by 574
Self-citationA common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia
Yang, S.-K., Hong, M., Baek, J., Choi, H., Zhao, W., Jung, Y., Haritunians, T., Ye, B. D., Kim, K.-J., Park, S. H., et al. (2014) · Nature Genetics · doi:10.1038/ng.3060 · Cited by 549
Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?
Pui, C.-H., Mullighan, C. G., Evans, W. E., & Relling, M. V. (2012) · Blood · doi:10.1182/blood-2012-05-378943 · Cited by 500
Self-citationEvans, W. E., Hon, Y. Y., Bomgaars, L., Coutre, S., Holdsworth, M., Janco, R., Kalwinsky, D., Keller, F., Khatib, Z., Margolin, J., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.8.2293 · Cited by 400
Self-citationBURCHENAL, J. H., MURPHY, M. L., ELLISON, R. R., SYKES, M. P., TAN, T. C., LEONE, L. A., KARNOF-SKY, D. A., CRAVER, L. F., DARGEON, H. W., & RHOADS, C. P. (1953) · Blood · doi:10.1182/blood.v8.11.965.965 · Cited by 397
Prognostic Importance of 6-Mercaptopurine Dose Intensity in Acute Lymphoblastic Leukemia
Relling, M. V., Hancock, M. L., Boyett, J. M., Pui, C.-H., & Evans, W. E. (1999) · Blood · doi:10.1182/blood.v93.9.2817 · Cited by 395
Self-citationThiopurine Methyltransferase Genotype Predicts Therapy-Limiting Severe Toxicity from Azathioprine
Black, A. J., McLeod, H. L., Capell, H. A., Powrie, R. H., Matowe, L. K., Pritchard, S. C., Collie-Duguid, E. S. R., & Reid, D. M. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-9-199811010-00007 · Cited by 374
Bhatia, S., Landier, W., Shangguan, M., Hageman, L., Schaible, A. N., Carter, A. R., Hanby, C. L., Leisenring, W., Yasui, Y., Kornegay, N. M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.9924 · Cited by 340
Self-citationPG4KDS: A model for the clinical implementation of pre‐emptive pharmacogenetics
Hoffman, J. M., Haidar, C. E., Wilkinson, M. R., Crews, K. R., Baker, D. K., Kornegay, N. M., Yang, W., Pui, C., Reiss, U. M., Gaur, A. H., et al. (2014) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31391 · Cited by 276
Self-citationAncestry and pharmacogenomics of relapse in acute lymphoblastic leukemia
Yang, J. J., Cheng, C., Devidas, M., Cao, X., Fan, Y., Campana, D., Yang, W., Neale, G., Cox, N. J., Scheet, P., et al. (2011) · Nature Genetics · doi:10.1038/ng.763 · Cited by 274
Self-citationTai, H.-L., Krynetski, E. Y., Schuetz, E. G., Yanishevski, Y., & Evans, W. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6444 · Cited by 259
Self-citationA Genomewide Admixture Mapping Panel for Hispanic/Latino Populations
Mao, X., Bigham, A. W., Mei, R., Gutierrez, G., Weiss, K. M., Brutsaert, T. D., Leon-Velarde, F., Moore, L. G., Vargas, E., McKeigue, P. M., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/518564 · Cited by 235
Drug dosage and remission duration in childhood lymphocytic leukemia
Pinkel, D. P., Hernandez, K., Borella, L. D., Holton, C. P., Aur, R. J. A., Samoy, G., & Pratt, C. B. (1971) · Cancer · Cited by 234
McLeod, H., Relling, M., Liu, Q., Pui, C., & Evans, W. (1995) · Blood · doi:10.1182/blood.v85.7.1897.bloodjournal8571897 · Cited by 218
Self-citationBhatia, S., Landier, W., Hageman, L., Kim, H., Chen, Y., Crews, K. R., Evans, W. E., Bostrom, B., Casillas, J., Dickens, D. S., et al. (2014) · Blood · doi:10.1182/blood-2014-01-552166 · Cited by 203
Self-citationTransporter-Mediated Protection against Thiopurine-Induced Hematopoietic Toxicity
Krishnamurthy, P. C., Schwab, M. G., Takenaka, K., Nachagari, D., Morgan, J., Leslie, M., Du, W., Boyd, K. L., Cheok, M. H.-C., Nakauchi, H., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6790 · Cited by 141
Self-citationSchmiegelow, K., Schrøder, H. D., Gustafsson, G., Kristinsson, J. A., Glomstein, A., Salmi, T., & WRANNE, L. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.2.345 · Cited by 141
Systemic Exposure to Mercaptopurine as a Prognostic Factor in Acute Lymphocytic Leukemia in Children
Koren, G., Ferrazzini, G., Sulh, H., Langevin, A. M., Kapelushnik, J., Klein, J., Giesbrecht, E., Soldin, S. J., & Greenberg, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230104 · Cited by 138
Thiopurine methyltransferase in acute lymphoblastic leukemia
Relling, M. V., Pui, C., Cheng, C., & Evans, W. E. (2006) · Blood · doi:10.1182/blood-2005-08-3379 · Cited by 130
Self-citationWang, L., Nguyen, T. V., McLaughlin, R. W., Sikkink, L. A., Ramírez-Alvarado, M., & Weinshilboum, R. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502352102 · Cited by 111
Toyoda, Y., Manabe, A., Tsuchida, M., Hanada, R., Ikuta, K., Okimoto, Y., Ohara, A., Ohkawa, Y., Mori, T., Ishimoto, K., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.7.1508 · Cited by 107
Human MTH3 (NUDT18) Protein Hydrolyzes Oxidized Forms of Guanosine and Deoxyguanosine Diphosphates
Takagi, Y., Setoyama, D., Ito, R., Kamiya, H., Yamagata, Y., & Sekiguchi, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.363010 · Cited by 105
Mouse MTH2 protein which prevents mutations caused by 8-oxoguanine nucleotides
Cai, J., Ishibashi, T., Takagi, Y., Hayakawa, H., & Sekiguchi, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00864-7 · Cited by 102
Thiopurines: Factors influencing toxicity and response
Fotoohi, A. K., Coulthard, S. A., & Albertioni, F. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.01.006 · Cited by 74
Pharmacogenomics and Patient Care: One Size Does Not Fit All
Giacomini, K. M., Yee, S. W., Ratain, M. J., Weinshilboum, R. M., Kamatani, N., & Nakamura, Y. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003471 · Cited by 63
Kham, S. K. Y., Soh, C. K., Liu, T. C., Chan, Y. H., Ariffin, H., Tan, P. L., & Yeoh, A. E. J. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0426-x · Cited by 55
Cited by
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
Pui, C.-H., Yang, J. J., Hunger, S. P., Pieters, R., Schrappe, M., Biondi, A., Vora, A., Baruchel, A., Silverman, L. B., Schmiegelow, K., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.1636 · Cited by 1,007
Self-citationCancer health disparities in racial/ethnic minorities in the United States
Zavala, V. A., Bracci, P. M., Carethers, J. M., Carvajal-Carmona, L., Coggins, N. B., Cruz-Correa, M. R., Davis, M., de Smith, A. J., Dutil, J., Figueiredo, J. C., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01038-6 · Cited by 912
Self-citationPharmacogenomics in the clinic
Relling, M. V., & Evans, W. E. (2015) · Nature · doi:10.1038/nature15817 · Cited by 904
Self-citationEvidence-based clinical practice guidelines for inflammatory bowel disease
Matsuoka, K., Kobayashi, T., Ueno, F., Matsui, T., Hirai, F., Inoue, N., Kato, J., Kobayashi, K., Kobayashi, K., Koganei, K., et al. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1439-1 · Cited by 698
Pediatric acute lymphoblastic leukemia
Inaba, H., & Mullighan, C. G. (2020) · Haematologica · doi:10.3324/haematol.2020.247031 · Cited by 696
Metadata
- Authors
- Yang, J. J., Landier, W., Yang, W., Liu, C., Hageman, L., Cheng, C., Pei, D., Chen, Y., Crews, K. R., Kornegay, N., Wong, F. L., Evans, W. E., Pui, C.-H., Bhatia, S., & Relling, M. V.
- Venue
- Journal of Clinical Oncology
- Published
- 2015-04-10
- Volume
- 33
- Issue
- 11
- Pages
- 1235-1242
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2109000403
- Cited by
- 445
- References
- 38
- FWCI
- 37.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.